J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio

Johnson & Johnson (JNJ) announced that it has entered into a definitive agreement to acquire medical device company Shockwave Medical (SWAV) for approximately $13.1 billion. The acquisition will strengthen JNJ’s MedTech cardiovascular portfolio.The acquisition will add Shockwave’s leading IVL intravascular lithotripsy (IVL) technology to JNJ’s MedTech business, thus strengthening its position in high-growth cardiovascular intervention segments – coronary artery disease (CAD) and peripheral artery disease (P ...